Molecular mechanisms of endothelial no synthase uncoupling

Current Pharmaceutical Design

Volumn 20, Issue 22, 2014, Pages 3548-3553

  Luo, Suxin ^a   Lei, Han ^a   Qin, Honghua ^b   Xia, Yong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Endothelial NO synthase; NO; Superoxide; Tetrahydrobiopterin; Uncoupling

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; SUPEROXIDE; TETRAHYDROBIOPTERIN; NITRIC OXIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CATALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ENDOTHELIUM CELL; METABOLISM;

ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84906794400     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113196660746     Document Type: Article

References (59)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmac Rev 1991; 43: 109-42.
2. Bredt DS, Snyder SH. Nitric oxide: a physiological messenger molecule. Annu Rev Biochem 1994; 63: 175-95.
3. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-8.
4. Knowles RG, Moncada S. Nitric oxide synthases in mammals, Biochem J 1994; 298 (Pt 2): 249-58.
5. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299: 818-24.
6. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284, R1-R12.
7. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995; 57: 737-69.
8. Cho HJ, Xie QW, Calaycay J, et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599-604.
9. Heinzel B, John M, Klatt P, Bohme E, Mayer B. Ca2+/Calmodulin- dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992; 281: 627-30.
10. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 1992; 267: 24173-6.
11. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 2001; 276: 14533-6.
12. Harrison DG, Minor RL, Guerra R, Quillen JE, Sellke FW. Endothelial dysfunction in atherosclerosis. In Rubanyi GM (ed.), Cardiovascular Significance of Endothelium-derived Vasoactive Factors, Futura, Mount Kisko, NY 1991; pp: 263-80.
13. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-44.
14. Griffith OW, Stuehr DJ. Nitric oxide synthase: properties and catalytic mechanism. Annu Rev Physiol 1995; 57: 707-36.
15. Vasquez-Vivar J, Hogg N, Martasek P, Karoui H, Pritchard KA Jr, Kalyanaraman B. Tetrahydrobioptein-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274: 26736-42.
16. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine- depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93: 6770-4.
17. Culcasi M, Lafon-Cazal M, Pietri S, Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem 1994; 269: 12589-93.
18. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
19. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997; 94: 6954-8.
20. Xia Y, Roman LJ, Masters BSS, Zweier JL. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998; 273: 22635-9.
21. Mungrue IN, Gros R, You X, et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 2002; 109: 735-43.
22. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998; 273: 25804-8.
23. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-5.
24. Stuehr DJ, Wei CC, Wang Z, Hille R. Exploring the redox reactions between heme and tetrahydrobiopterin in the nitric oxide synthases. Dalton Trans 2005; 21: 3427-35.
25. Wei CC, Wang ZQ, Durra D, et al. The three nitric-oxide synthases differ in their kinetics of tetrahydrobiopterin radical formation, hemedioxy reduction, and arginine hydroxylation. J Biol Chem 2005; 280: 8929-35.
26. Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 2008; 294: H1530-40.
27. Crabtree MJ, Tatham AL, Al-Wakeel Y, et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 2009; 284: 1136-44.
28. Cho HJ, Martin E, Xie QW, Sassa S, Nathan C. Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin. Proc Natl Acad Sci USA 1995; 92: 11514-8.
29. Presta A, Siddhanta U, Wu C, et al. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry 1998; 37: 298-310.
30. Papapetropoulos A, Rudci RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 1999; 43: 509-20
31. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997; 100: 2146-52.
32. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997; 272: 18522-5.
33. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997; 272: 25907-12.
34. Xia Y, Berlowitz CO, Zweier JL. Caveolin inhibits superoxide generation from nitric oxide synthase. The FASEB J 2000; A191.
35. Karuppiah K, Druhan LJ, Chen CA, et al. Suppression of eNOS- derived superoxide by caveolin-1: a biopterin-dependent mechanism. Am J Physiol Heart Circ Physiol 2011; 301: H903-H911.
36. Garcia-Cardena G, Fan R, Shah V, et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998; 392: 821-4.
37. Balligand JL. Heat shock protein 90 in endothelial nitric oxide synthase signaling. Circ Res 2000; 90: 838-41.
38. Pratt WB. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol 1998; 217: 420-34.
39. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J Biol Chem 2000; 275: 5026-30.
40. Fontana J, Fulton D, Chen Y, et al. Domin mapping studies that the M domain of hsp90 serves as a molecular scaffold to regulate Akt- dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 2002; 90: 866-73.
41. Pritchard KA Jr, Ackerman AW, Gross ER, et al. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 2001; 276: 17621-4, 2001.
42. Dikalov S, Landmesser U, Harrison DG. Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitricoxide synthase. J Biol Chem 2002; 277: 25480-5.
43. Song Y, Cardounel AJ, Zweier JL, Xia Y. Heat shock protein 90 prevents superoxide generation from neuronal nitric oxide synthase: implications in NOS regulation. Biochemistry 2002; 41: 10616-22.
44. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by muti-site eNOS phosphorylation. J Mol Cell Cardiol 2007; 42: 271-9.
45. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium- derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
46. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation. Nature 1999; 399: 601-5.
47. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996; 98: 894-8.
48. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-9.
49. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium- independent" eNOS activation by phosphorylation. J Biol Chem 2000; 275: 6123-8.
50. Chen W, Yoshida M, Dong Y, Xia Y. Phosphorylation of serine 1179 enhances superoxide generation from endothelial nitric oxide synthase. Circulation 2003; 108: 4-30.
51. Lin MI, Fulton D, Babbitt R, et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem 2003; 278: 44719-26.
52. Chen CA, Wang TY, Varadharaj S, et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010; 468: 1115-8.
53. Crabtree MJ, Brixey R, Batchelor H, Hale AB, Channon KM. Integrated redox sensor and effector functions for tetrahydrobiopterin- and glutathionylation-dependent endothelial nitric-oxide synthase uncoupling. J Biol Chem 2013; 288: 561-9.
54. Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-7.
55. Cooke JP, Oka RK. Atherogenesis and the arginine hypothesis. Curr Atheroscler Rep 2001; 3: 252-9.
56. Tran CT, Leiper JM, Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler Suppl 2003; 4: 33-40.
57. Antoniades C, Shirodaria C, Leeson P, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 2009; 30: 1142-50.
58. Cardounel, AJ, Xia Y, Zweier, JL. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric oxide synthase: differences in the effects of mono- methyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. J Biol Chem 2005; 280: 7540-9.
59. Xia, Y. Superoxide generation from nitric oxide synthase. Antioxid Redox Signal 2007; 9: 1773-8.